← SynDRA
EVP4593
SynDRA canonical compound SYN1950526 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | NFkB pathway inhibitor |
|---|
Mechanisms of action (all sources)
Cross-references
- PubChem CID: 509554
- TTD: D03BXA
Synonyms
- AG-F-89549
- QNZ
- 6-Amino-4-(4-phenoxyphenylethylamino)quinazoline
- QNZ (EVP4593)
- N4-(4-phenoxyphenethyl)quinazoline-4,6-diamine
- 4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine
- EVP 4593
- NF-kB activation inhibitor
- QNZ(EVP4593)
- N4-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine
- Curator_000005
- 6-amino-4-(4-phenoxyphenylethylamino) quinazoline
- SCHEMBL157421
- CHEMBL522502
- GTPL6012
- 4,6-Quinazolinediamine, N4-[2-(4-phenoxyphenyl)ethyl]-
- DTXSID00333507
- EX-A182
- HMS3229K22
- HMS3402B14
- HMS3649N20
- HMS3652J12
- HMS3674K05
- HMS3748A11
- HMS3886M05
- AMY24212
- BCP07901
- CAY10470
- ZINC1489490
- 5?-Dihydro Testosterone Undecanoate
- MFCD06411436
- s4902
- AKOS022175523
- CCG-206870
- CS-1515
- AC-32085
- AS-67689
- DA-42127
- HY-13812
Look up EVP4593 in the interactive SynDRA portal →